Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid levels and bone mineral density.

Daniel H Solomon1, Jerry Avorn, Claire F Canning

  • 1Division of Pharmacoepidemiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02120, USA. dhsolomon@partners.org

The American Journal of Medicine
|December 28, 2005
PubMed
Summary

This study found no link between cholesterol levels and bone density in adults not taking lipid-lowering drugs. These findings do not support a connection between lipid profiles and bone health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep medications and sleep disturbances across middle aged pre- or peri-menopausal women of different race and ethnicities: A SWAN pharmacoepidemiology cohort study.

Pharmacoepidemiology and drug safety·2020
Same author

Comparison of a new 3-item self-reported measure of adherence to medication with pharmacy claims data in patients with cardiometabolic disease.

American heart journal·2020
Same author

Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement : Exploratory Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial.

Annals of internal medicine·2020
Same author

The "Infodemic" of COVID-19.

Arthritis & rheumatology (Hoboken, N.J.)·2020
Same author

Pulmonary Adverse Events in Patients Receiving Low-Dose Methotrexate in the Randomized, Double-Blind, Placebo-Controlled Cardiovascular Inflammation Reduction Trial.

Arthritis & rheumatology (Hoboken, N.J.)·2020
Same author

Delayed Denosumab Injections and Fracture Risk Among Patients With Osteoporosis : A Population-Based Cohort Study.

Annals of internal medicine·2020

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Cardiovascular Health

Background:

  • Observational studies suggest statins may reduce fracture risk, but randomized trials haven't confirmed this.
  • Hyperlipidemia is a common indication for statin use.
  • A potential association between lipid levels and bone mineral density could explain the observed discrepancy.

Purpose of the Study:

  • To investigate the relationship between lipid levels and bone mineral density.
  • To determine if lipid profiles influence bone health in individuals not using lipid-lowering therapy.

Main Methods:

  • Analysis of 13,592 participants from the National Health and Nutritional Examination Survey (NHANES) III.
  • Exclusion of participants using lipid-lowering therapy.

Related Experiment Videos

  • Examination of bone mineral density across quintiles of total cholesterol, LDL, and HDL, with multivariable adjustments for confounders.

    • Main Results:

    • Crude analyses showed higher total cholesterol and LDL associated with lower bone density, and higher HDL with greater bone density.
    • After adjusting for age, sex, body mass index, and other confounders, no significant relationship was found.
    • P-values for trend in adjusted models for total cholesterol, LDL, and HDL were all greater than 0.1.

    Conclusions:

    • The study's findings do not support an association between lipid levels and bone mineral density.
    • This suggests that lipid levels themselves are unlikely to explain the discrepancy between observational studies and randomized controlled trials regarding statins and fracture risk.